A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia
- 295 Downloads
Recurrent focal neuropathy with liability to pressure palsies is a relatively frequent autosomal-dominant demyelinating neuropathy linked to peripheral myelin protein 22 (PMP22) gene deletions. The combination of PMP22 gene mutations with other genetic variants is known to cause a more severe phenotype than expected. We present the case of a patient with severe orthostatic hypotension since 12 years of age, who inherited a PMP22 gene deletion from his father. Genetic double trouble was suspected because of selective sympathetic autonomic disturbances. Through exome-sequencing analysis, we identified two novel mutations in the dopamine beta hydroxylase gene. Moreover, with interactome analysis, we excluded a further influence on the origin of the disease by variants in other genes. This case increases the number of unique patients presenting with dopamine-β-hydroxylase deficiency and of cases with genetically proven double trouble. Finding the right, complete diagnosis is crucial to obtain adequate medical care and appropriate genetic counseling.
KeywordsRecurrent focal neuropathy with liability to pressure palsies Dopamine-β-hydroxylase deficiency Exome sequencing, dysautonomia
We are grateful to the patient and his family members for their participation in the study. This project was supported by University of Bologna, RFO 2012 to P.C.
Compliance with ethical standards
Conflicts of interest
The authors report no conflict of interests.
- 4.Robertson D, Garland EM, Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (1993) Dopamine beta-hydroxylase deficiency. In: Seattle, WA (ed) Genereviews, University of Washington, Seattle. Initial Posting: September 4, 2003; Last Update: January 24, 2013Google Scholar
- 8.Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S, Springall DR, Watson L (1990) Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q J Med 75:617–633PubMedGoogle Scholar
- 9.Gentric A, Fouilhoux A, Caroff M, Mottier D, Jouquan J (1994) Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient: clinical experience. J Age Relat Disord 6:7–8Google Scholar
- 14.Deinum J, Steenbergen-Spanjers GC, Jansen M, Boomsma F, Lenders JW, van Ittersum FJ, Hück N, van den Heuvel LP, Wevers RA (2004) DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41:e38PubMedCentralCrossRefPubMedGoogle Scholar
- 16.Erez A, Li J, Geraghty MT, Ben-Shachar S, Cooper ML, Mensing DE, Vonalt KD, Ou Z, Pursley AN, Chinault AC, Patel A, Cheung SW, Sahoo T (2010) Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiency-case report and review of the literature. Am J Med Genet A 152A:732–736CrossRefPubMedGoogle Scholar
- 18.Kim CH, Leung A, Huh YH, Yang E, Kim DJ, Leblanc P, Ryu H, Kim K, Kim DW, Garland EM, Raj SR, Biaggioni I, Robertson D, Kim KS (2011) Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase. J Biol Chem 286:9196–9204PubMedCentralCrossRefPubMedGoogle Scholar